1 / 23

Synthesis of Eicosanoids, Glycerolipids and Isoprenoids

Synthesis of Eicosanoids, Glycerolipids and Isoprenoids. Eicosanoids. Eicosanoids are important regulatory molecules Referred to as local regulators. Function where they are produced. Two classes: Prostaglandins/thromboxanes, and Leukotrienes

dara
Download Presentation

Synthesis of Eicosanoids, Glycerolipids and Isoprenoids

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Synthesis of Eicosanoids, Glycerolipids and Isoprenoids

  2. Eicosanoids • Eicosanoids are important regulatory molecules • Referred to as local regulators. Function where they are produced. • Two classes: Prostaglandins/thromboxanes, and Leukotrienes • Prostaglandins – mediate pains sensitivity, inflammation and swelling • Thromboxanes – involved in blood clotting, constriction of arteries • Leukotrienes – attract white cells, involved inflammatory diseases (asthma, arthritis, etc..)

  3. Eicosanoids

  4. Eicosanoid Synthesis • C20 unsaturated fatty acids (i.e. arachidonic acid (20:4D5,8,11,14) are precursors • Prostaglandins and Thromboxanes are synthesized by a cyclooxygenase pathway • Leukotirenes are synthesized by a lipoxygenase pathway cyclooxygenase

  5. Arachidonic acid present in membrane lipids are released for eicosanoid synthesis in the cell interior by phospholipase A2

  6. Cyclooxygenase (COX) Inhibitors • Two COX isozymes: COX-1 and COX-2. • COX-1 – important in regulating mucin secretion in stomach • COX-2 – promotes pain and inflammation and fever (involved in prostaglandin synthesis). • Asprin (acetylsalicylate) non-specific COX inhibitor. Acts by acetylating an essential serine residue in the active site. • Because asprin inhibits COX-1, causes stomach upset and other side effects. • New drugs (Vioxx and Celebrex) specifically inhibit COX-2

  7. Glycerolipid Biosynthesis • Important for the synthesis of membrane lipids and triacylglycerol • Synthesis occurs primarily in ER • Phosphatidic acid (PA) is the precursor for all other glycerolipids in eukaryotes • PA is made either into diacylglycerol (DAG) or CDP-DAG

  8. Glycerolipid Biosynthesis • Phosphatidic acid is the precursor for all other glycerolipids

  9. Isoprenoid Synthesis • Involves formation of isopentenyl pyrophosphate (IPP) monmers. • IPP is conjugated in a head to tail manner to generate polyprenyl compounds.

  10. Formation of the isopentenyl pyrophosphate (IPP) via mevalonate pathway. • Primary pathway for isprenoid synthesis in animals and cytosolic isoprenoid synthesis in plants

  11. Phosphomevalonate kinase pyrohosphomevalonate decarboxylase Mevalonate kinase Formation of the isopentenyl pyrophosphate (IPP)

  12. Two Fates of HMG-CoA

  13. Bacteria and Plants Synthesize IPP via Non-Mevalonate Pathway • In plants and most bacteria, IPP is synthesized from the condensation of glyceraldehyde-3-phosphate (3 carbons) and pyruvate (3 carbons). • Forms a 5 carbon intermediate through transketolase type reaction (transfer of 2 carbon aldehyde from pyruvate to G-3-P). • Occurs in chloroplast of plants. Involved in synthesis of chlorophyll, carotenoids, Vitamins A, E and K.

  14. Very recent discovery (1996) Pathway still not fully understood. New pathway provides enzyme targets for new herbicidal and anti-microbial compounds

  15. Condensation of IPP into Polyprenyl Compounds IPP isomerase Dimethylallyl pryophosphate

  16. IPP Isomerase prenyltransferase prenyltransferase Squalene synthase Cholesterol Synthesis from IPP

  17. Squalene monooxygenase 2,3-oxidosqualene lanosterol cyclase 20 steps cholesterol

  18. Regulation of HMG-CoA Reductase • As rate-limiting step, it is the principal site of regulation in cholesterol synthesis • 1) Phosphorylation by cAMP-dependent kinases inactivates the reductase • 2) Degradation of HMG-CoA reductase - half-life is 3 hrs and depends on cholesterol level • 3) Gene expression (mRNA production) is controlled by cholesterol levels

  19. Inhibiting Cholesterol Synthesis • HMG-CoA reductase is the key - the rate-limiting step in cholesterol biosynthesis • Lovastatin (mevinolin) blocks HMG-CoA reductase and prevents synthesis of cholesterol • Lovastatin is an (inactive) lactone • In the body, the lactone is hydrolyzed to mevinolinic acid, a competitive (TSA!) inhibitor of the reductase, Ki = 0.6 nM!

More Related